Acta Scientific Microbiology (ISSN: 2581-3226)

Review Article Volume 6 Issue 3

The Challenges During the COVID-19 Waves in India – from an Intensivists Experience

Wadhawan S1, Husain F1*, Sonkar SC2,3, Koner BC2,4

1Department of Anaesthesiology and Intensive Care, Maulana Azad Medical College and associated Lok Nayak Hospital, New Delhi, India

2Multidisciplinary Research Unit (MRU), Maulana Azad Medical College and Associated Hospital, New Delhi, India

3Delhi, School of Public Health, The Institution of Eminence (IoE), University of Delhi, Delhi, India

4Department of Biochemistry, Maulana Azad Medical College and Associated Hospital, New Delhi, India

*Corresponding Author: Husain F, Department of Anaesthesiology and Intensive Care, Maulana Azad Medical College and associated Lok Nayak Hospital, New Delhi, India.

Received: January 24, 2023; Published: February 09, 2023

Abstract

The unprecedented rise in cases during the second wave of COVID-19 in India unembellished life-threatening consequences as demand-supply gaps were increased many folds. It led to a significant constraint on the existing medical supplies. Additionally, an unprecedented rise in mortality was observed in the unvaccinated young and middle-aged population. An evidence-based observation and experience including the challenges faced by intensivists as to why the second wave was more dangerous than the first one, could help in identifying the potential areas to target with future control strategies.

Keywords: COVID-19; SARS-CoV-2; Pandemic Challenges; Intensivists; ICU; Pandemic Wave; Delhi

References

  1. Pandemic Influenza Preparedness and Response: A WHO Guidance Document. Geneva: World Health Organization; (2009).
  2. Worldometer population data India (2022).
  3. Dubey A, Bansal A, Sonkar SC, Goswami B, Makwane N, Manchanda V, Koner BC. “In-house assembled protective devices in laboratory safety against SARS-nCoV-2 in the clinical biochemistry laboratory of a COVID dedicated hospital”. medRxiv (2008).
  4. Dubey A, Kotnala G, Mandal TK, Sonkar SC, Singh VK, Guru SA, Bansal A, Irungbam M, Husain F, Goswami B, Kotnala RK, Saxena S, Sharma SK, Saxena KN, Sharma C, Kumar S, Aswal DK, Manchanda V, Koner BC. “Evidence of the presence of SARS-CoV-2 virus in atmospheric air and surfaces of a dedicated COVID hospital”. Journal of Medical Virology9 (2021): 5339-5349.
  5. Garg S, Singh VK, Sonkar SC, Kelkar H, Singh S, Garg S, Arya M, Husain F, Chandra L, Chitkara A, Talukdar T, Goswami B, Koner BC. “Pattern of serum protein capillary electrophoretogram in SARS- CoV-2 infection”. Clinica Chimica Acta 527 (2022): 11-16.
  6. Irungbam M, Chitkara A, Singh VK, Sonkar SC, Dubey A, Bansal A, Shrivastava R, Goswami B, Manchanda V, Saxena S, Saxena R, Garg S, Husain F, Talukdar T, Kumar D, Koner BC. “Evaluation of Performance of Detection of Immunoglobulin G and Immunoglobulin M Antibody Against Spike Protein of SARS-CoV-2 by a Rapid Kit in a Real-Life Hospital Setting”. Frontiers in Microbiology 13 (2022): 802292.
  7. Gupta A, Sural S, Gupta A, Rousa S, Koner BC, Bhalotra A, Chawla R. “Positive QuantiFERON test and the severity of COVID-19 disease: A prospective study”. Indian Journal of Tuberculosis4 (2021): 474-480.
  8. Malhotra V, Basu S, Sharma N, Kumar S, Garg S, Dushyant K, Borle A. “Outcomes among 10,314 hospitalized COVID-19 patients at a tertiary care government hospital in Delhi, India”. Journal of Medical Virology7 (2021): 4553-4558.
  9. Arora G, Taneja J, Bhardwaj P, Goyal S, Naidu K, Yadav SK, Saluja D, Jetly S. “Adverse events and breakthrough infections associated with COVID-19 vaccination in the Indian population”. Journal of Medical Virology (2022): 1-8.
  10. A Joint guidelines release and recommendation for management of COVID-19 in adults.
  11. Husain F., et al. “Evidence-guided, experience-based, patient compatible, a 3-step protocol for managing moderate to severe category COVID-19 infections”. IAR Journal of Anaesthesiology and Critical Care 1 (2021): 12-14.
  12. Scala R and Pisani L. “Noninvasive ventilation in acute respiratory failure: which recipe for success?” European Respiratory Society 149 (2018): 180029.
  13. Yadav UN, Rayamajhee B, Mistry SK, Parsekar SS, Mishra SK. “A Syndemic Perspective on the Management of Non-communicable Diseases Amid the COVID-19 Pandemic in Low- and Middle-Income Countries”. Frontiers in Public Health 8 (2020): 508.
  14. Meher R, Meher R, Wadhwa V, Kumar V, Shisha Phanbuh D, Sharma R, Singh I, Rathore PK, Goel R, Arora R, Garg S, Kumar S, Kumar J, Agarwal M, Singh M, Khurana N, Sagar T, Manchanda V, Saxena S. “COVID associated mucormycosis: A preliminary study from a dedicated COVID Hospital in Delhi”. American Journal of Otolaryngology1 (2022): 103220.
  15. Wadhawan S Husain F, Agarwal M. “The New Normal Anesthesiologist and the Challenging Post-COVID-19 Mucormycosis Patients − Our Experience”. MAMC Journal of Medical Sciences 7 (2021): 126-135.
  16. Soni VK, Mehta A, Ratre YK, Tiwari AK, Amit A, Singh RP, Sonkar SC, Chaturvedi N, Shukla D, Vishvakarma NK. “Curcumin, a traditional spice component, can hold the promise against COVID-19?” European Journal of Pharmacology 886 (2020): 173551.
  17. Mahilkar S, Agrawal S, Chaudhary S, Parikh S, Sonkar SC, Verma DK, Chitalia V, Mehta D, Koner BC, Vijay N, Shastri J, Sunil S. “SARS-CoV-2 variants: Impact on biological and clinical outcome”. Frontiers in Medicine (Lausanne) 9 (2022): 995960.

Citation

Citation: Wadhawan S., et al. “The Challenges During the COVID-19 Waves in India – from an Intensivists Experience". Acta Scientific Microbiology 6.3 (2023): 35-40.

Copyright

Copyright: © 2022 Wadhawan S., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days

Indexed In






News and Events


Contact US